UPDATE : Monday, May 25, 2020
‘Parasiticide showed antiviral effect as potential Covid-19 drug’ by Jeong Sae-im 2020-04-24 12:27
French envoy visits Pasteur Korea to watch Covid-19 research by Jeong Sae-im 2020-04-23 17:13
Multinational drugmakers donated ₩30 billion last year by Kim Yun-mi 2020-04-23 15:09
4 drugs recorded two-digit sales growth in Q1 despite Covid-19 by Jeong Sae-im 2020-04-23 12:18
Medytox’s faking data unpunishable due to expired statute of limitations by Jeong Sae-im 2020-04-22 11:28
Abclon derives clinical materials for CAR-T treatment of ovarian cancer by Shim Hyun-tai 2020-04-21 17:49
Multidisciplinary cure is mainstream cancer treatment but cumbersome by Park Gi-taek 2020-04-21 17:09
Whistleblowers, shareholders furious over Medytox’s rebuttal by Jeong Sae-im 2020-04-21 15:19
ImmuneMed confident of drug candidate’s effect on Covid-19 by Jeong Sae-im 2020-04-21 13:23
Medytox files suit to cancel administrative order by Shim Hyun-tai 2020-04-20 16:37
DM Bio signs CDMO contract with Abion for antibody treatment by Shim Hyun-tai 2020-04-17 16:03
Medytox CEO charged with making, selling botulinum toxin illegally by Jeong Sae-im 2020-04-17 16:00
Researchers to test asthma drug to treat Covid-19 by Kim Yun-mi 2020-04-16 16:20
Bukwang to test its antiviral drug against Covid-19 by Jeong Sae-im 2020-04-16 12:20
Opdivo’s indication expanded to esophageal squamous cell carcinoma by Kim Yun-mi 2020-04-16 10:48
Pasteur, Daewoong to co-develop COVID-19 drug from parasiticide by Shim Hyun-tai 2020-04-14 17:49
Gilead revised clinical design of potential COVID-19 drug remdesivir. Why? by Kim Yun-mi 2020-04-10 15:36
Executive salaries highest at Samsung Biologics, Celltrion by Jeong Sae-im 2020-04-09 11:13
Review of cancer drug benefits delayed amid social distancing by Kim Yun-mi 2020-04-08 13:46
Jeil’s oral cancer treatment wins extended indication for NSCLC by Shim Hyun-tai 2020-04-06 15:33
Back to Top